Brief: Ascelia Pharma Q2 EBIT SEK -23 Million
21/08/2025 06:30
Aug 21 (Reuters) - Ascelia Pharma Q2 cash flow from operations SEK -18 million. Q2 EPS SEK -0.2
ACE — Ascelia Pharma AB News Story
0.000.00%
Last trade - 00:00- SEK393.94m
- SEK360.74m
Last trade - 00:00